- Home
- RMTI vs GDTC Comparison
RMTI vs GDTC Comparison
Compare RMTI & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMTI
- GDTC
- Stock Information
- Founded
- RMTI 1994
- GDTC 2018
- Country
- RMTI United States
- GDTC Singapore
- Employees
- RMTI N/A
- GDTC N/A
- Industry
- RMTI Biotechnology: Pharmaceutical Preparations
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- RMTI Health Care
- GDTC Health Care
- Exchange
- RMTI Nasdaq
- GDTC Nasdaq
- Market Cap
- RMTI 32.5M
- GDTC 21.5M
- IPO Year
- RMTI 1998
- GDTC 2023
- Fundamental
- Price
- RMTI $0.98
- GDTC $1.89
- Analyst Decision
- RMTI Strong Buy
- GDTC Buy
- Analyst Count
- RMTI 2
- GDTC 1
- Target Price
- RMTI $4.00
- GDTC $5.00
- AVG Volume (30 Days)
- RMTI 449.6K
- GDTC 18.1K
- Earning Date
- RMTI 08-14-2025
- GDTC 01-01-0001
- Dividend Yield
- RMTI N/A
- GDTC N/A
- EPS Growth
- RMTI N/A
- GDTC N/A
- EPS
- RMTI N/A
- GDTC N/A
- Revenue
- RMTI $97,727,000.00
- GDTC $368,838.00
- Revenue This Year
- RMTI N/A
- GDTC $5.37
- Revenue Next Year
- RMTI $11.16
- GDTC N/A
- P/E Ratio
- RMTI N/A
- GDTC N/A
- Revenue Growth
- RMTI 12.82
- GDTC N/A
- 52 Week Low
- RMTI $0.78
- GDTC $1.20
- 52 Week High
- RMTI $5.15
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- RMTI 44.49
- GDTC 37.08
- Support Level
- RMTI $1.08
- GDTC $1.85
- Resistance Level
- RMTI $1.18
- GDTC $1.95
- Average True Range (ATR)
- RMTI 0.09
- GDTC 0.10
- MACD
- RMTI -0.01
- GDTC -0.02
- Stochastic Oscillator
- RMTI 5.71
- GDTC 28.00
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.